Bristol Myers Squibb (BMY) Selling, General & Administrative (2009 - 2026)
Bristol Myers Squibb's Selling, General & Administrative was $1.83 billion in Q2 2026, up 6.6% from $1.71 billion a year earlier and up 12.9% from the prior quarter.
Bristol Myers Squibb (BMY) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bristol Myers Squibb's Selling, General & Administrative was $7.41 billion through Jun 30, 2026, unchanged year-over-year; for FY2025, it came in at $7.27 billion, down 13.6% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of -1.1% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $8.41 billion in FY2024 (+8.3%), $7.77 billion in FY2023 (-0.5%), $7.81 billion in FY2022 (+1.6%) and $7.69 billion in FY2021 (+0.4%).
- Quarterly Selling, General & Administrative has moved between $1.58 billion (Q1 2025) and $2.37 billion (Q1 2024) over five years.
- Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with an average decline of 5.1% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q1 2024 (growth of 34.3%); the worst was Q1 2025 (a decline of 33.1%).
- Per Business Quant data, BMY's Selling, General & Administrative in the three quarters before Q2 2026 was $1.62 billion (Q1 2026), $2.18 billion (Q4 2025) and $1.79 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Bristol Myers Squibb | 120.21 Bn | 71.48 Bn | 9.25 Bn | 1.83 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Bn |
| Mar 31, 2026 | 1.62 Bn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 1.79 Bn |
| Jun 30, 2025 | 1.71 Bn |
| Mar 31, 2025 | 1.58 Bn |
| Dec 31, 2024 | 2.14 Bn |
| Sep 30, 2024 | 1.98 Bn |
| Jun 30, 2024 | 1.93 Bn |
| Mar 31, 2024 | 2.37 Bn |
| Dec 31, 2023 | 2.07 Bn |
| Sep 30, 2023 | 2.00 Bn |
| Jun 30, 2023 | 1.93 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 1.93 Bn |
| Jun 30, 2022 | 1.79 Bn |
| Mar 31, 2022 | 1.83 Bn |
| Dec 31, 2021 | 2.35 Bn |
| Sep 30, 2021 | 1.79 Bn |
Bristol Myers Squibb Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();